Is Liver Cancer Treatable? (2026 Update)

Yes, liver cancer is treated with a combination of resection, transplantation, locoregional therapy, and systemic drug therapy depending on stage and liver function. For patients diagnosed in Korea between 2019 and 2023, the 5-year relative survival rate was 40.4% — a nationwide cancer registry figure, not the outcome of any single hospital.

Key Takeaways

• Korea's 5-year relative survival rate for liver cancer is 40.4% (National Cancer Registry Statistics 2019–2023, National Cancer Center Korea's Central Cancer Registry).
• The U.S. SEER 5-year relative survival rate for liver and intrahepatic bile duct cancer is 21.9% (2016–2022); both figures are national-level statistics, not results from a specific hospital.
• Liver cancer treatment decisions take into account not only tumor size, number, and vascular invasion, but also liver function grade (Child-Pugh) and overall physical condition.
• Treatment options include resection, radiofrequency ablation, transarterial chemoembolization, liver transplantation, and systemic drug therapy (immune checkpoint inhibitors and targeted therapy), combined according to stage.
• Survival rates are population averages, not predictions for any individual patient, so the treatment direction should be determined through consultation with your medical team.

Can liver cancer be diagnosed without a biopsy?

• Yes. Unlike many other cancers, liver cancer can often be diagnosed through imaging alone.
• In patients with cirrhosis or chronic hepatitis, a diagnosis can be established when contrast-enhanced CT or MRI shows the characteristic blood flow pattern — strong enhancement in the arterial phase followed by washout. Tumor markers such as AFP are reviewed alongside the imaging. A biopsy is only added when imaging findings are ambiguous or metastasis from another cancer is suspected.

What treatment is given according to stage?

• In very early and early stages — small tumors, few in number, good liver function — surgical resection is the first choice; if resection isn't feasible, radiofrequency ablation is used, and for patients with reduced liver function who meet the criteria, liver transplantation is the definitive treatment.
• In intermediate stages with multiple tumors confined to the liver, transarterial chemoembolization (TACE) is the mainstay, sometimes combined with radioembolization, stereotactic body radiotherapy (SBRT), or particle therapy.
• In advanced stages with vascular invasion or spread beyond the liver, systemic drug therapy combining immune checkpoint inhibitors with anti-angiogenic agents is the current first-line standard, with oral targeted therapies used depending on the case.
• When liver function is significantly impaired, chemotherapy can further damage the liver, so the focus shifts to symptom control, preserving liver function, and evaluating transplant eligibility.

What is the typical sequence from diagnosis to treatment?

• Step 1: Diagnosis using contrast-enhanced CT/MRI and tumor markers such as AFP and PIVKA-II, with biopsy added if needed.
• Step 2: Staging (e.g., BCLC) is determined by combining tumor number, size, vascular invasion, liver function (Child-Pugh), and overall condition.
• Step 3: A multidisciplinary team selects from resection, radiofrequency ablation, embolization, transplantation, or systemic drug therapy based on stage.
• Step 4: After treatment, contrast-enhanced CT/MRI and AFP testing are repeated every few months for the first 1–2 years, then at longer intervals. Patients with hepatitis B or C continue antiviral therapy long-term.

Can foreign nationals receive a liver transplant in Korea?

• It is possible if criteria are met, but review under Korean law is required.
• Deceased-donor organs are allocated to domestic waitlisted patients first, so foreign patients are generally considered only for living-donor liver transplantation using a family member as donor. Candidates must have tumors within size and number criteria and no spread beyond the liver. Eligibility and required documentation are explained during the remote review (pre-arrival review) stage. Korea has extensive, long-established experience in living-donor liver transplantation.

FAQ — Do I need to keep taking hepatitis B medication?

Yes, antiviral medication should be continued without interruption before, during, and after liver cancer treatment. Since liver cancer usually develops on top of chronic hepatitis or cirrhosis, protecting liver function preserves more treatment options going forward. Arrangements can be made to obtain a prescription in Korea to take home.

FAQ — How long is recovery after treatment?

It depends on the treatment method. After radiofrequency ablation or embolization, fever and abdominal pain are common for a day or two, and patients are generally fit to return home within about ten days. Typical target recovery periods are 2–3 weeks for liver resection, 3–5 weeks for particle therapy, and 6–8 weeks or more for liver transplantation, with outpatient follow-up continuing afterward.

Sources and Notes

• This article is based on National Cancer Registry Statistics 2019–2023 (National Cancer Center Korea's Central Cancer Registry), SEER 2016–2022, and general patient-level information consistent with the National Cancer Information Center and NCCN patient guidelines.
• This content is provided for general medical information purposes only. Diagnosis, treatment methods, and outcomes may vary by individual condition. Accurate diagnosis and treatment decisions should always be made in consultation with your medical team.